In NSCLC, the expression of CXCR3 and its ligands is elevated within the tumor microenvironment (TME), influencing the activity of natural killer (NK) cells and T cells, which are critical for the surveillance and elimination of cancer cells (Butler et al., 2017). This evidence concerns the gene CXCR3 and cancer.